Used in research for its potential as a cyclin-dependent kinase (CDK) inhibitor, particularly targeting CDK4 and CDK6. These kinases play key roles in cell cycle regulation, making the compound relevant in studies of cancer therapeutics. It has shown activity in preclinical models against certain tumor types by inducing cell cycle arrest and inhibiting proliferation. Its application is mainly focused on oncology drug development, especially in exploring targeted therapies for solid tumors and hematological malignancies.